Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Bonus News from MarketBeat Media
Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?Author: Ryan Hasson. First Published: 5/12/2026. 
Key Points
- Rocket Lab surged over 40% in two trading sessions following its Q1 earnings report, closing at a new all-time high of $117.35 on Tuesday and pushing its YTD gain to 68%.
- The move was driven by record Q1 revenue, a $2.2 billion backlog, the largest launch contract in company history, and a flurry of positive announcements.
- With the RSI approaching overbought territory, the fundamental story remains compelling, but short-term caution might be warranted after such a parabolic move.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Rocket Lab (NASDAQ: RKLB) just had one of the most extraordinary weeks in its history as a public company. The stock closed at a new all-time high of $117.35 on Tuesday, after surging more than 40% in just a few days following its Q1 2026 earnings report. From the low-$80s before the closing bell on May 7 to nearly $120 just two trading sessions later, the move has been explosive.
Tesla's most recent SEC filing contains a single line showing $12 billion in revenue from a new venture Elon Musk has been quietly building inside the company — one that has nothing to do with cars, robots, space, or AI.
Blackstone calls the underlying opportunity a $23 trillion market. On July 22, Elon is expected to go public with it. Former hedge fund manager Adam O'Dell says he already knows what's coming — and is sharing the name and ticker of one of his top picks to play it, free. Watch Adam O'Dell's full briefing and claim your free ticker now
The stock is now up about 70% year to date and more than 400% over the past 12 months. For investors watching from the sidelines, the question is natural: Is this still a buying opportunity, or has the easy money already been made? What Drove the Recent Explosive SurgeFirst things first, it’s important to understand what catalyzed the move. The earnings report was the initial catalyst. Record quarterly revenue of $200.3 million, up 63.5% year over year, a record $2.2 billion backlog, Q2 guidance that easily topped consensus, and the disclosure that Rocket Lab booked more launches in Q1 2026 alone than in all of 2025. That was more than enough to ignite a major breakout and a surge in a single session on May 8. But the earnings report was only part of the story. Alongside the results, Rocket Lab announced a relentless pace of news flow, as CEO Peter Beck described it. The company signed its largest-ever launch contract with a confidential customer, covering five Neutron and three Electron missions through 2029. It secured a $30 million HASTE hypersonic launch contract with Anduril. It was selected alongside Raytheon to support the Golden Dome Space-Based Interceptor program. And it announced the acquisition of Motiv Space Systems, adding Mars-proven space robotics to its vertical integration strategy. Stack all of that together in a single evening, and the market's reaction becomes easier to understand. The Analyst Community Is Moving Fast Following the Latest ResultsWall Street has been scrambling to catch up following the results and wave of announcements. TD Cowen recently raised its price target to $120, which is Street-high. Needham matched that with a raise to $120, establishing a joint Street-high target with a Buy rating. Citigroup reiterated its Outperform rating on RKLB, and Citizens JMP boosted its target to $95 from $85 while maintaining its Market Outperform rating. The consensus target, across 17 analysts, is now the highest it has ever been at $91.79, while maintaining a consensus Moderate Buy rating. The broader sector tailwind and sentiment are also worth noting. SpaceX IPO speculation continues to inject excitement and capital into an array of space stocks, and most notably Rocket Lab. As the closest publicly traded competitor to SpaceX, Rocket Lab remains the primary beneficiary of that sentiment and flow. Should You Buy Rocket Lab Now or Wait?From a fundamental perspective, the company's story is stronger than ever. The $2.2 billion backlog has grown more than 20% sequentially. The largest-ever launch contract in company history has already been signed with an undisclosed customer. Neutron remains on track for its Q4 2026 debut, with five contracts already committed. A national security revenue stream is now materializing through the Golden Dome and hypersonic programs. It’s become clear that RKLB is no longer just a speculative story, but rather a business with real, contracted, and durable revenue. But after surging more than 40% over two trading sessions, the stock has almost certainly gotten ahead of itself in the short term. The RSI has now entered overbought territory, approaching the mid-70s. The price sits materially above all key moving averages, with Tuesday’s close significantly extended from all key short- to mid-term SMAs. And the consensus analyst target is now roughly 20% below the current share price. All of that points to a stock that could use time to consolidate before the next leg higher. Just as the stock built out a base before breaking above $90, it could benefit from another period of digestion above $100 before continuing higher. For long-term investors, the thesis remains compelling. For those considering a new position, patience may be rewarded. A period of consolidation above a key support level would offer a far more favorable risk-reward entry than chasing it at all-time highs after a parabolic move. |
Post a Comment
Post a Comment